itraconazole has been researched along with Febrile Neutropenia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, H; Fujiwara, SI; Fukuda, T; Gotoh, M; Iino, M; Jo, Y; Kanda, Y; Kimura, SI; Matsumura, I; Nakamura, S; Okamoto, A; Oyake, T; Saburi, Y; Sakaida, E; Shiratori, S; Takamatsu, Y; Tamura, K; Yamaguchi, H; Yamanouchi, J | 1 |
| Cheong, JW; Cho, IS; Choi, YJ; Jang, JH; Jo, DY; Kang, HJ; Kim, BS; Kim, HG; Kim, HY; Kim, JS; Kim, JY; Kim, MK; Kim, SH; Kim, SJ; Kim, YS; Kwak, JY; Lee, DG; Lee, JH; Lee, SM; Min, YH; Mun, YC; Park, BB; Park, J; Ryoo, HM; Yang, DH | 1 |
| Choi, CW; Jang, JH; Jeong, SH; Kim, DY; Kim, JS; Kim, SH; Mun, YC; Park, JS | 1 |
| Brossart, P; Felder, L; Hahn-Ast, C; Hein, R; Hellmich, M; Mayer, K; Mückter, S; Rachow, T; Ruhnke, M; Schwab, K; von Lilienfeld-Toal, M | 1 |
| Fondell, A; Fustino, N; Hess, J; Malik, J; Rokes, C | 1 |
1 review(s) available for itraconazole and Febrile Neutropenia
| Article | Year |
|---|---|
Presentation and Treatment of Histoplasmosis in Pediatric Oncology Patients: Case Series and Review of the Literature.
Topics: Abdominal Neoplasms; Adolescent; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Burkitt Lymphoma; Child; Child, Preschool; Combined Modality Therapy; Desmoplastic Small Round Cell Tumor; Diagnosis, Differential; Early Diagnosis; Endemic Diseases; Febrile Neutropenia; Histoplasmosis; Humans; Immunocompromised Host; Infant; Iowa; Itraconazole; Lung; Lung Neoplasms; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sarcoma | 2017 |
3 trial(s) available for itraconazole and Febrile Neutropenia
| Article | Year |
|---|---|
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial.
Topics: Adult; Aged; Antifungal Agents; Febrile Neutropenia; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Leukocyte Count; Male; Micafungin; Middle Aged; Mycoses; Neutrophils; Young Adult | 2020 |
Success rate and risk factors for failure of empirical antifungal therapy with itraconazole in patients with hematological malignancies: a multicenter, prospective, open-label, observational study in Korea.
Topics: 14-alpha Demethylase Inhibitors; Adolescent; Adult; Aged; Antifungal Agents; Aspergillosis; Candidiasis; Coccidioidomycosis; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Itraconazole; Male; Mannans; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2014 |
Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antifungal Agents; Echinocandins; Empirical Research; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Itraconazole; Length of Stay; Lipopeptides; Male; Micafungin; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2016 |
1 other study(ies) available for itraconazole and Febrile Neutropenia
| Article | Year |
|---|---|
Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia.
Topics: Aged; Antifungal Agents; Cohort Studies; Drug Delivery Systems; Empirical Research; Febrile Neutropenia; Female; Humans; Itraconazole; Male; Middle Aged; Post-Exposure Prophylaxis; Retrospective Studies; Survival Rate; Treatment Outcome; Triazoles | 2016 |